News & Views | Published:

Cancer vaccine targets leukemia

Nature Medicine volume 9, pages 13541356 (2003) | Download Citation

Subjects

Effective cancer vaccines targeted against specific antigens have eluded researchers for decades. When combined with a drug, one such vaccine now shrinks tumors in a mouse model of promyelocytic leukemia (pages 1413–1417).

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & Cancer J. Sci. Am. 3, 568–569 (1997).

  2. 2.

    et al. Nat. Med. 9, 1413–1417 (2003).

  3. 3.

    et al. J. Clin. Oncol. 18, 3894–3903 (2000).

  4. 4.

    Curr. Opin. Invest. Drugs 2, 844–888 (2001).

  5. 5.

    et al. J. Clin. Oncol. 20, 4169–4180 (2002).

  6. 6.

    et al. Cancer Res. 63, 2127–2133 (2003).

  7. 7.

    et al. Cancer Immunol. Immunother. 52, 387–395 (2003).

  8. 8.

    , & J. Clin. Oncol. 21, 2342–2348 (2003).

  9. 9.

    et al. Am. J. Obstet. Gynecol. 188, 916–926 (2003).

  10. 10.

    , , , & Blood, published online 31 July 2003 (doi:10.1182/blood-2003-02-0412).

  11. 11.

    et al. Proc. Natl. Acad. Sci. USA 99, 9468–9473 (2002).

Download references

Author information

Affiliations

  1. John Donnelly is at Chiron Vaccines, 4560 Horton Street, Emeryville, California 94608, USA. John_Donnelly@chiron.com

    • John Donnelly

Authors

  1. Search for John Donnelly in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm1103-1354

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing